Filter
99
Filtered Results: 99
Text search:
heterologous
Featured
Recommendations
9
New Publications
14
Language
Document type
Guidelines
39
No document type
32
Studies & Reports
12
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
South Africa
3
Latin America and the Carribbean
3
Africa
3
Nigeria
2
Mozambique
2
Bolivia
2
Paraguay
2
Russia
2
Uganda
1
Philippines
1
Germany
1
Tanzania
1
Indonesia
1
Ecuador
1
Chile
1
East and Southern Africa
1
Asia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
34
Clinical Guidelines
10
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
48
NTDs
6
Rapid Response
5
TB
4
NCDs
3
Zika
2
Mental Health
2
Ebola
1
Polio
1
Global Health Education
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Division of Noncommunicable Diseases | draft guidelines on diagnosis and management of a chronic immune-mediated enteropathy called celiac disease. This disease is caused is mainly caused in genetically susceptible individuals by ingestion of gluten proteins that are present in wheat, barley and oat...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
J Mov Disord > Volume 11(2); 2018 > Article
Review Article
J Mov Disord 2018; 11(2): 53-64.
Published online: May 30, 2018
DOI: https://doi.org/10.14802/jmd.17028
Introduction
Chapter A.13
O Protocolo de Vigilância Epidemiológica e Sanitária de Eventos Adversos Pós-Vacinação (EAPV), é o documento de referência nacional para a vigilância das vacinas COVID-19. Além disso, complementará, com os demais protocolos definidos pelo Ministério da Saúde, as ações empreendidas par...
National Operationalisation Plan for the COVID-19 Vaccine : 13th edition
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of...
